Aisling M. Redmond

1.5k total citations
18 papers, 665 citations indexed

About

Aisling M. Redmond is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Aisling M. Redmond has authored 18 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Aisling M. Redmond's work include Estrogen and related hormone effects (7 papers), HER2/EGFR in Cancer Research (4 papers) and Genomics and Chromatin Dynamics (4 papers). Aisling M. Redmond is often cited by papers focused on Estrogen and related hormone effects (7 papers), HER2/EGFR in Cancer Research (4 papers) and Genomics and Chromatin Dynamics (4 papers). Aisling M. Redmond collaborates with scholars based in United Kingdom, Ireland and United States. Aisling M. Redmond's co-authors include Leonie S. Young, Hong-Wu Chen, Jianming Xu, Yuhui Yuan, Lan Liao, Li Qin, Bert W. O’Malley, Jason S. Carroll, Arnold D. Hill and Marie McIlroy and has published in prestigious journals such as Nature Communications, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Aisling M. Redmond

17 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aisling M. Redmond United Kingdom 14 405 223 200 196 86 18 665
Shiming Jiang China 18 967 2.4× 332 1.5× 221 1.1× 178 0.9× 67 0.8× 40 1.3k
Jessica Kao United States 5 633 1.6× 154 0.7× 426 2.1× 352 1.8× 86 1.0× 6 1.0k
Sónia Moniz Portugal 14 452 1.1× 133 0.6× 153 0.8× 188 1.0× 111 1.3× 18 817
Zhibo Yang China 13 487 1.2× 97 0.4× 362 1.8× 150 0.8× 70 0.8× 35 825
Shashirekha Shetty United States 10 584 1.4× 92 0.4× 214 1.1× 269 1.4× 53 0.6× 31 856
Eva Schuster Austria 15 486 1.2× 132 0.6× 333 1.7× 281 1.4× 87 1.0× 37 867
Sally Gaddis United States 12 549 1.4× 107 0.5× 219 1.1× 223 1.1× 57 0.7× 16 769
Colin R. James United Kingdom 8 314 0.8× 177 0.8× 259 1.3× 189 1.0× 77 0.9× 9 574
Swee Seong Wong United States 6 540 1.3× 88 0.4× 146 0.7× 102 0.5× 85 1.0× 6 688
Wei Jiao China 14 373 0.9× 93 0.4× 58 0.3× 287 1.5× 48 0.6× 30 566

Countries citing papers authored by Aisling M. Redmond

Since Specialization
Citations

This map shows the geographic impact of Aisling M. Redmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisling M. Redmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisling M. Redmond more than expected).

Fields of papers citing papers by Aisling M. Redmond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisling M. Redmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisling M. Redmond. The network helps show where Aisling M. Redmond may publish in the future.

Co-authorship network of co-authors of Aisling M. Redmond

This figure shows the co-authorship network connecting the top 25 collaborators of Aisling M. Redmond. A scholar is included among the top collaborators of Aisling M. Redmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisling M. Redmond. Aisling M. Redmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nowicki-Osuch, Karol, Lizhe Zhuang, Tik Shing Cheung, et al.. (2023). Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia. Cancer Discovery. 13(6). 1346–1363. 32 indexed citations
2.
Redmond, Aisling M., et al.. (2022). In vitro and in vivo assessments of the genotoxic potential of 3‐chloroallyl alcohol. Environmental and Molecular Mutagenesis. 64(1). 26–38. 1 indexed citations
3.
Katz‐Summercorn, Annalise, Sriganesh Jammula, Anna Frangou, et al.. (2022). Multi-omic cross-sectional cohort study of pre-malignant Barrett’s esophagus reveals early structural variation and retrotransposon activity. Nature Communications. 13(1). 1407–1407. 11 indexed citations
4.
Roller, Maša, Ericca Stamper, Diego Villar, et al.. (2021). LINE retrotransposons characterize mammalian tissue-specific and evolutionarily dynamic regulatory regions. Genome biology. 22(1). 62–62. 39 indexed citations
5.
Ococks, E., Alexander M. Frankell, Nicola Grehan, et al.. (2021). Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling. Annals of Oncology. 32(4). 522–532. 66 indexed citations
6.
Stojic, Lovorka, Aaron T. L. Lun, Patrice Mascalchi, et al.. (2020). A high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell division. Nature Communications. 11(1). 1851–1851. 46 indexed citations
7.
Redmond, Aisling M., Soleilmane Omarjee, Igor Chernukhin, Muriel Le Romancer, & Jason S. Carroll. (2019). Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation. PLoS ONE. 14(11). e0225180–e0225180. 7 indexed citations
8.
Charmsaz, Sara, Damir Varešlija, Ailís Fagan, et al.. (2018). Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer. Oncogene. 37(15). 2008–2021. 24 indexed citations
9.
Wong, Emily, Bianca M. Schmitt, Anastasiya Kazachenka, et al.. (2017). Interplay of cis and trans mechanisms driving transcription factor binding and gene expression evolution. Nature Communications. 8(1). 1092–1092. 48 indexed citations
10.
Varešlija, Damir, Jean McBryan, Ailís Fagan, et al.. (2016). Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors. Clinical Cancer Research. 22(11). 2765–2777. 17 indexed citations
11.
Varešlija, Damir, Jean McBryan, Ailís Fagan, et al.. (2015). Abstract P3-05-24: Adaptation to AI therapy in breast cancer can induce dynamic alterations in ER activity resulting in estrogen independent metastatic tumours. Cancer Research. 75(9_Supplement). P3–5.
12.
Redmond, Aisling M., Christopher Byrne, Gordon D. Brown, et al.. (2014). Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells. Oncogene. 34(29). 3871–3880. 30 indexed citations
13.
Redmond, Aisling M., Jean McBryan, Sinéad Cocchiglia, et al.. (2011). RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer. FEBS Letters. 585(15). 2537–2544. 23 indexed citations
14.
Redmond, Aisling M., Fiona T. Bane, Marie McIlroy, et al.. (2009). Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence. Clinical Cancer Research. 15(6). 2098–2106. 69 indexed citations
15.
Redmond, Aisling M. & Jason S. Carroll. (2009). Defining and targeting transcription factors in cancer. Genome Biology. 10(7). 311–311. 20 indexed citations
16.
Dillon, Mary F., Gabrielle Kelly, Aisling M. Redmond, et al.. (2008). Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients. Endocrine Related Cancer. 15(3). 745–753. 23 indexed citations
17.
Qin, Li, Lan Liao, Aisling M. Redmond, et al.. (2008). The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression. Molecular and Cellular Biology. 28(19). 5937–5950. 156 indexed citations
18.
Alazawi, D, Gabrielle Kelly, Aisling M. Redmond, et al.. (2007). Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer. Oncogene. 27(21). 3021–3031. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiming Jiang Breakdown of academic impact, for papers by Jessica Kao Breakdown of academic impact, for papers by Sónia Moniz Breakdown of academic impact, for papers by Zhibo Yang Breakdown of academic impact, for papers by Shashirekha Shetty Breakdown of academic impact, for papers by Eva Schuster Breakdown of academic impact, for papers by Sally Gaddis Breakdown of academic impact, for papers by Colin R. James Breakdown of academic impact, for papers by Swee Seong Wong Breakdown of academic impact, for papers by Wei Jiao
Rankless by CCL
2026